Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
AstraZeneca AB v. Zydus Pharmaceuticals (USA) Inc.
Case Number:
1:18-cv-00664
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
October 15, 2021
Zydus Infringed AstraZeneca's Diabetes Drug IP, Judge Rules
A Delaware federal judge held Friday that Zydus Pharmaceuticals infringed an AstraZeneca patent for a diabetes drug, saying Zydus failed during a four-day bench trial to prove that any of the asserted claims were obvious.
-
May 13, 2021
IP Forecast: Cox Case To Restart Patent Jury Trials In Del.
Cox Communications is getting ready to defend its high-speed networking technology from a patent-holding company's infringement claims in the first patent trial in Delaware federal court to go before a jury since the pandemic began — plus all the other major intellectual property matters that are on deck for the coming week.